The ethanol extract of Zingiber zerumbet Smith attenuates non-alcoholic fatty liver disease in hamsters fed on high-fat diet

Food and Chemical Toxicology

Volumn 65, Issue , 2014, Pages 33-42

  Chang, Chia Ju ^a   Liou, Shorong Shii ^a   Tzeng, Thing Fong ^a   Liu, I Min ^a  

^a TAJEN UNIVERSITY   (Taiwan)

Author keywords

High fat diet; Non alcoholic fatty liver disease; Peroxisome proliferator activated receptor ; Sterol regulatory element binding protein 1c; Zingiber zerumbet rhizome

Indexed keywords

ALCOHOL; CHOLESTEROL; FATTY ACID; INSULIN; LIPID; MESSENGER RNA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR ALPHA; PLANT EXTRACT; STEROL REGULATORY ELEMENT BINDING PROTEIN 1C; TRIACYLGLYCEROL; UNCLASSIFIED DRUG; ZINGIBER ZERUMBET EXTRACT; ACYL COA OXIDASE 1; ACYL COENZYME A OXIDASE; CARNITINE PALMITOYLTRANSFERASE I; FENOFIBRATE; GINGEROL; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INTERLEUKIN 6; KAEMPFEROL; LIVER PROTECTIVE AGENT; LOW DENSITY LIPOPROTEIN CHOLESTEROL; MONOCYTE CHEMOTACTIC PROTEIN 1; OXIDOREDUCTASE; QUERCETIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DRUG MECHANISM; FATTY ACID BLOOD LEVEL; FATTY ACID OXIDATION; FATTY LIVER; FEEDING BEHAVIOR; GENE TARGETING; HAMSTER; HISTOPATHOLOGY; INSULIN RESISTANCE; LIPID DIET; LIPID LIVER LEVEL; MALE; NONALCOHOLIC FATTY LIVER; NONHUMAN; SYRIAN HAMSTER; TAIWAN; TRIACYLGLYCEROL BLOOD LEVEL; UPREGULATION; ZINGIBER ZERUMBET; ANIMAL TISSUE; BODY WEIGHT; FOOD INTAKE; HISTOLOGY; LIPID STORAGE; LIVER WEIGHT; PHYTOCHEMISTRY; PROTEIN EXPRESSION; TREATMENT DURATION;

HIGH-FAT DIET; NON-ALCOHOLIC FATTY LIVER DISEASE; PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR Α; STEROL REGULATORY ELEMENT-BINDING PROTEIN-1C; ZINGIBER ZERUMBET RHIZOME;

ANIMALS; BASE SEQUENCE; CRICETINAE; CYTOKINES; DIET, HIGH-FAT; DNA PRIMERS; ETHANOL; FATTY LIVER; INFLAMMATION MEDIATORS; INSULIN; INSULIN RESISTANCE; LIPID METABOLISM; LIVER; MALE; MESOCRICETUS; PLANT EXTRACTS; REAL-TIME POLYMERASE CHAIN REACTION; RNA, MESSENGER; STEROL REGULATORY ELEMENT BINDING PROTEIN 1; ZINGIBERACEAE;

CRICETINAE; ZINGIBER ZERUMBET;

EID: 84891907741     PISSN: 02786915     EISSN: 18736351     Source Type: Journal    
DOI: 10.1016/j.fct.2013.11.048     Document Type: Article

References (31)

1. Bartlett K., Eaton S. Mitochondrial Beta-oxidation. Eur. J. Biochem. 2004, 271:462-469.
2. Beaton M.D. Current treatment options for nonalcoholic fatty liver disease and nonalcoholic steatohepatitis. Can. J. Gastroenterol. 2012, 26:353-357.
3. Bhathena J., Kulamarva A., Martoni C., Urbanska A.M., Malhotra M., Paul A., Prakash S. Diet-induced metabolic hamster model of nonalcoholic fatty liver disease. Diabetes Metab. Syndr. Obes. 2011, 4:195-203.
4. Braunersreuther V., Viviani G.L., Mach F., Montecucco F. Role of cytokines and chemokines in non-alcoholic fatty liver disease. World J. Gastroenterol. 2012, 18:727-735.
5. Chan S.M., Sun R.Q., Zeng X.Y., Choong Z.H., Wang H., Watt M.J., Ye J.M. Activation of PPARα ameliorates hepatic insulin resistance and steatosis in high fructose-fed mice despite increased endoplasmic reticulum stress. Diabetes 2013, 62:2095-2105.
6. Chang C.J., Tzeng T.F., Liou S.S., Chang Y.S., Liu I.M. Beneficial impact of Zingiber zerumbet on insulin sensitivity in fructose-fed rats. Planta Med. 2012, 78:317-325.
7. Chang C.J., Tzeng T.F., Liou S.S., Chang Y.S., Liu I.M. Regulation of lipid disorders by ethanol extracts from Zingiber zerumbet in high-fat diet-induced rats. Food Chem. 2012, 132:460-467.
8. Crozier A., Jaganath I.B., Clifford M.N. Dietary phenolics: chemistry, bioavailability and effects on health. Nat. Prod. Rep. 2009, 26:1001-1043.
9. Dobrzyn A., Ntambi J.M. The role of stearoyl-CoA desaturase in the control of metabolism. Prostaglandins Leukot. Essent. Fatty Acids 2005, 73:35-41.
10. Folch J., Lees M., Sloane-Stanley G.H. A simple method for the isolation and purification of total lipids from animal tissues. J. Biol. Chem. 1957, 226:497-506.
11. Hodge H.C., Downs W.L., Panner B.S., Smith D.W., Maynard E.A. Oral toxicity and metabolism of diuron (N-(3,4-dichlorophenyl)-N', N'-dimethylurea) in rats and dogs. Food Cosmet. Toxicol. 1967, 5:513-531.
12. Huang J., Jia Y., Fu T., Viswakarma N., Bai L., Rao M.S., Zhu Y., Borensztajn J., Reddy J.K. Sustained activation of PPARα by endogenous ligands increases hepatic fatty acid oxidation and prevents obesity in ob/ob mice. FASEB J. 2012, 26:628-638.
13. Ibrahim M.Y., Abdul A.B., Ibrahim T.A., AbdelWahab S.I., Elhassan M.M., Mohan S. Attenuation of cisplatin-induced nephrotoxicity in rats using zerumbone. Afr. J. Biotechnol. 2010, 9:4434-4441.
14. Ibrahim M.A., Kelleni M., Geddawy A. Nonalcoholic fatty liver disease: current and potential therapies. Life Sci. 2013, 92:114-118.
15. Jensen-Urstad A.P., Semenkovich C.F. Fatty acid synthase and liver triglyceride metabolism: housekeeper or messenger?. Biochim. Biophys. Acta 2012, 1821:747-753.
16. Kanda H., Tateya S., Tamori Y., Kotani K., Hiasa K., Kitazawa R., Kitazawa S., Miyachi H., Maeda S., Egashira K., Kasuga M. MCP-1 contributes to macrophage infiltration into adipose tissue, insulin resistance, and hepatic steatosis in obesity. J. Clin. Invest. 2006, 116:1494-1505.
17. Kraja A.T., Province M.A., Straka R.J., Ordovas J.M., Borecki I.B., Arnett D.K. Fenofibrate and metabolic syndrome. Endocr. Metab. Immune Disord. Drug Targets 2010, 10:138-148.
18. Li Y., Ding L., Hassan W., Abdelkader D., Shang J. Adipokines and hepatic insulin resistance. J. Diabetes. Res. 2013, 2013:170532.
19. Lieber C.S., Leo M.A., Mak K.M., Xu Y., Cao Q., Ren C., Ponomarenko A., DeCarli L.M. Model of nonalcoholic steatohepatitis. Am. J. Clin. Nutr. 2004, 79:502-509.
20. Livak K.J., Schmittgen T.D. Analysis of relative gene expression data using real-time quantitative PCR and the 2-δδCT method. Methods 2001, 25:402-408.
21. Mao J., DeMayo F.J., Li H., Abu-Elheiga L., Gu Z., Shaikenov T.E., Kordari P., Chirala S.S., Heird W.C., Wakil S.J. Liver-specific deletion of acetyl-CoA carboxylase 1 reduces hepatic triglyceride accumulation without affecting glucose homeostasis. Proc. Natl. Acad. Sci. USA 2006, 103:8552-8557.
22. Matthews D.R., Hosker J.P., Rudenski A.S., Naylor B.A., Treacher D.F., Turner R.C. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985, 28:412-419.
23. Mormone E., George J., Nieto N. Molecular pathogenesis of hepatic fibrosis and current therapeutic approaches. Chem. Biol. Interact. 2011, 193:225-231.
24. Osborne T.F. Sterol regulatory element-binding proteins (SREBPs): key regulators of nutritional homeostasis and insulin action. J. Biol. Chem. 2000, 275:32379-32382.
25. Paschos P., Paletas K. Non alcoholic fatty liver disease and metabolic syndrome. Hippokratia 2009, 13:9-19.
26. Poirier Y., Antonenkov V.D., Glumoff T., Hiltunen J.K. Peroxisomal beta-oxidation-a metabolic pathway with multiple functions. Biochim. Biophys. Acta 2006, 1763:1413-1426.
27. Rector R.S., Payne R.M., Ibdah J.A. Mitochondrial trifunctional protein defects: clinical implications and therapeutic approaches. Adv. Drug Deliv. Rev. 2008, 60:1488-1496.
28. Reddy J.K., Hashimoto T. Peroxisomal beta-oxidation and peroxisome proliferator activated receptor alpha: an adaptive metabolic system. Annu. Rev. Nutr. 2001, 21:193-230.
29. Ruslay S., Abas F., Shaari K., Zainal Z., Maulidiani, Sirat H., Israf D.A., Lajis N.H. Characterization of the components present in the active fractions of health gingers (Curcuma xanthorrhiza and Zingiber zerumbet) by HPLC-DAD-ESIMS. Food Chem. 2007, 104:1183-1191.
30. Van Heek M., Compton D.S., France C.F., Tedesco R.P., Fawzi A.B., Graziano M.P., Sybertz E.J., Strader C.D., Davis H.R. Diet-induced obese mice develop peripheral, but not central, resistance to leptin. J. Clin. Invest. 1997, 99:385-390.
31. Yob, N.J., Jofrry, S.M., Affandi, M.M., Teh, L.K., Salleh, M.Z., Zakaria, Z.A., 2011. Zingiber zerumbet (L.) Smith: a review of its ethnomedicinal, chemical, and pharmacological uses. Evid. Complement. Alternat. Med., 543216.